Loading...
•
Jun 30, 2024
TELA Bio Q2 2024 Earnings Report
TELA Bio reported an 11% increase in revenue compared to the same period in 2023, driven by increased unit sales, offset by decreased average selling prices. The company is reiterating its full-year revenue guidance.
Key Takeaways
TELA Bio reported revenue of $16.1 million for the second quarter of 2024, an 11% increase compared to the same period in 2023. The company is reiterating its 2024 revenue target of $74.5 million to $76.5 million.
Revenue increased by 11% to $16.1 million compared to Q2 2023.
Gross profit was $11.1 million, representing 69% of revenue.
Operating expenses were $22.6 million.
Net loss was $12.6 million.
Forward Guidance
TELA Bio is reiterating its 2024 revenue target of $74.5 million to $76.5 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...